{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:23:59Z","timestamp":1790036639842,"version":"4.0.1"},"reference-count":131,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Lipid Research"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.plipres.2012.11.001","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T06:01:54Z","timestamp":1354168914000},"page":"193-205","source":"Crossref","is-referenced-by-count":111,"title":["Bilirubin and beyond: A review of lipid status in Gilbert\u2019s syndrome and its relevance to cardiovascular disease protection"],"prefix":"10.1016","volume":"52","author":[{"given":"A.C.","family":"Bulmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.J.","family":"Verkade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.-H.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plipres.2012.11.001_b0005","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1053\/j.semperi.2011.02.010","article-title":"Neonatal screening for glucose-6-phosphate dehydrogenase deficiency: biochemical versus genetic technologies","volume":"35","author":"Kaplan","year":"2011","journal-title":"Semin Perinatol"},{"issue":"Pt. 3","key":"10.1016\/j.plipres.2012.11.001_b0010","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/000456329903600307","article-title":"Threshold concentration of unbound bilirubin to induce neurological deficits in a patient with type I Crigler\u2013Najjar syndrome","volume":"36","author":"Ihara","year":"1999","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.plipres.2012.11.001_b0015","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.atherosclerosis.2007.11.022","article-title":"Improved resistance to serum oxidation in Gilbert\u2019s syndrome: a mechanism for cardiovascular protection","volume":"199","author":"Bulmer","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2012.11.001_b0020","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1126\/science.3029864","article-title":"Bilirubin is an antioxidant of possible physiological importance","volume":"235","author":"Stocker","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.plipres.2012.11.001_b0025","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1089\/ars.2004.6.841","article-title":"Antioxidant activities of bile pigments","volume":"6","author":"Stocker","year":"2004","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.plipres.2012.11.001_b0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/clinchem\/40.1.18","article-title":"Association of low serum concentration of bilirubin with increased risk of coronary artery disease","volume":"40","author":"Schwertner","year":"1994","journal-title":"Clin Chem"},{"key":"10.1016\/j.plipres.2012.11.001_b0035","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0021-9150(01)00601-3","article-title":"Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels","volume":"160","author":"Vitek","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2012.11.001_b0040","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ajmg.10209","article-title":"Frequencies of UDP-glucuronosyltransferase 1 (UGT1A1) gene promoter polymorphisms among distinct ethnic groups from Brazil","volume":"108","author":"Fertrin","year":"2002","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.plipres.2012.11.001_b0045","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/j.1582-4934.2010.01098.x","article-title":"Bile acids decrease intracellular bilirubin levels in the cholestatic liver: implications for bile acid-mediated oxidative stress","volume":"15","author":"Muchova","year":"2011","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.plipres.2012.11.001_b0050","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0891-5849(95)00032-S","article-title":"Hyperbilirubinemia results in reduced oxidative injury in neonatal Gunn rats exposed to hyperoxia","volume":"19","author":"Dennery","year":"1995","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.plipres.2012.11.001_b0055","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/j.1440-1746.2008.05388.x","article-title":"Decreased oxidation susceptibility of plasma low density lipoproteins in patients with Gilbert\u2019s syndrome","volume":"23","author":"Yesilova","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.plipres.2012.11.001_b0060","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1194\/jlr.P013193","article-title":"Serum bilirubin levels in familial hypercholesterolemia: a new risk marker for cardiovascular disease?","volume":"52","author":"Nolting","year":"2011","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2012.11.001_b0065","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.freeradbiomed.2012.03.002","article-title":"Reduced circulating oxidized LDL is associated with hypocholesterolemia and enhanced thiol status in Gilbert\u2019s syndrome","volume":"52","author":"Boon","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.plipres.2012.11.001_b0070","first-page":"360","article-title":"Relationship between unconjugated hyperbilirubinemia and lipoprotein spectrum","volume":"32","author":"Ocadlik","year":"2011","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.plipres.2012.11.001_b0075","unstructured":"Wallner M, Marculescu R, Doberer D, Vitek L, Bulmer AC, Wagner KH. Cardiovascular protection in subjects with Gilbert syndrome: a significant effect of bilirubin on lipid metabolism unpublished results."},{"key":"10.1016\/j.plipres.2012.11.001_b0080","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1478-3231.2008.01716.x","article-title":"Bilirubin in clinical practice: a review","volume":"28","author":"Fevery","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.plipres.2012.11.001_b0085","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/978-1-4757-3401-0_17","article-title":"The heme oxygenase system and cellular defense mechanisms. Do HO-1 and HO-2 have different functions?","volume":"502","author":"Maines","year":"2001","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.plipres.2012.11.001_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2010.11.067","article-title":"Heme oxygenase-1 comes back to endoplasmic reticulum","volume":"404","author":"Kim","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.plipres.2012.11.001_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2423(06)43001-8","article-title":"The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases","volume":"43","author":"Vitek","year":"2007","journal-title":"Adv Clin Chem"},{"key":"10.1016\/j.plipres.2012.11.001_b0100","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1432-1033.1993.tb17939.x","article-title":"The structural characterization and bilirubin-binding properties of albumin herborn, a [Lys240\u2192Glu] albumin mutant","volume":"214","author":"Minchiotti","year":"1993","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.plipres.2012.11.001_b0105","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s005350070044","article-title":"Recent advances in bilirubin metabolism research: the molecular mechanism of hepatocyte bilirubin transport and its clinical relevance","volume":"35","author":"Kamisako","year":"2000","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.plipres.2012.11.001_b0110","doi-asserted-by":"crossref","first-page":"10852","DOI":"10.1074\/jbc.274.16.10852","article-title":"Unconjugated bilirubin exhibits spontaneous diffusion through model lipid bilayers and native hepatocyte membranes","volume":"274","author":"Zucker","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2012.11.001_b0115","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/0020-711X(88)90256-X","article-title":"Comparison of hepatic, renal and intestinal bilirubin UDP-glucuronyl transferase activities in rat microsomes","volume":"20","author":"Mottino","year":"1988","journal-title":"Int J Biochem"},{"key":"10.1016\/j.plipres.2012.11.001_b0120","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cvsm.2009.02.007","article-title":"Important clinical syndromes associated with liver disease","volume":"39","author":"Rothuizen","year":"2009","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"10.1016\/j.plipres.2012.11.001_b0125","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1139\/y85-260","article-title":"Evidence for a secretory component in the handling of unconjugated bilirubin by the isolated perfused rat kidney","volume":"63","author":"Elias","year":"1985","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.plipres.2012.11.001_b0130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0304-4165(97)00003-2","article-title":"Transepithelial fate of bilirubin in the isolated rat kidney","volume":"1336","author":"Elias","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.plipres.2012.11.001_b0135","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1440-1746.2006.04564.x","article-title":"Urinary excretion of oxidative metabolites of bilirubin in subjects with Gilbert syndrome","volume":"22","author":"Vitek","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.plipres.2012.11.001_b0140","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/BF01951646","article-title":"Renal handling of bilirubin photoderivatives","volume":"43","author":"Elias","year":"1987","journal-title":"Experientia"},{"key":"10.1016\/j.plipres.2012.11.001_b0145","doi-asserted-by":"crossref","first-page":"G656","DOI":"10.1152\/ajpgi.00383.2001","article-title":"Increased renal expression of bilirubin glucuronide transporters in a rat model of obstructive jaundice","volume":"282","author":"Tanaka","year":"2002","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.plipres.2012.11.001_b0150","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/gut.2009.183921","article-title":"Acceleration of the gastrointestinal transit by polyethylene glycol effectively treats unconjugated hyperbilirubinaemia in gunn rats","volume":"59","author":"Cuperus","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.plipres.2012.11.001_b0155","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1542\/peds.92.1.86","article-title":"Superiority of oral agar and phototherapy combination in the treatment of neonatal hyperbilirubinemia","volume":"92","author":"Caglayan","year":"1993","journal-title":"Pediatrics"},{"key":"10.1016\/j.plipres.2012.11.001_b0160","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1203\/PDR.0b013e3181598cc5","article-title":"Orlistat treatment of unconjugated hyperbilirubinemia in Crigler\u2013Najjar disease: a randomized controlled trial","volume":"62","author":"Hafkamp","year":"2007","journal-title":"Pediatr Res"},{"key":"10.1016\/j.plipres.2012.11.001_b0165","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1203\/01.pdr.0000203180.79636.98","article-title":"Novel kinetic insights into treatment of unconjugated hyperbilirubinemia: phototherapy and orlistat treatment in Gunn rats","volume":"59","author":"Hafkamp","year":"2006","journal-title":"Pediatr Res"},{"key":"10.1016\/j.plipres.2012.11.001_b0170","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1067\/S0022-3476(03)00298-1","article-title":"Orlistat treatment increases fecal bilirubin excretion and decreases plasma bilirubin concentrations in hyperbilirubinemic Gunn rats","volume":"143","author":"Nishioka","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.plipres.2012.11.001_b0175","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1016\/j.bmc.2008.02.008","article-title":"In vitro permeability and stability of bile pigments and the effects of hydrophilic and lipophilic modification of biliverdin","volume":"16","author":"Bulmer","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.plipres.2012.11.001_b0180","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/j.1476-5381.2011.01413.x","article-title":"Bile pigment phamacokinetics and absorption in the rat: therapeutic potential for enteral administration","volume":"164","author":"Bulmer","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.plipres.2012.11.001_b0185","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1046\/j.1440-1746.2001.02495.x","article-title":"Role of UGT1A1 mutation in fasting hyperbilirubinemia","volume":"16","author":"Ishihara","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.plipres.2012.11.001_b0190","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2217\/14622416.9.6.703","article-title":"Pharmacogenetics of Gilbert\u2019s syndrome","volume":"9","author":"Strassburg","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.plipres.2012.11.001_b0195","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1056\/NEJM199511023331802","article-title":"The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert\u2019s syndrome","volume":"333","author":"Bosma","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.plipres.2012.11.001_b0200","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.bpg.2010.07.007","article-title":"Hyperbilirubinemia syndromes (Gilbert\u2013Meulengracht, Crigler\u2013Najjar, Dubin\u2013Johnson, and Rotor syndrome)","volume":"24","author":"Strassburg","year":"2010","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.plipres.2012.11.001_b0205","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1053\/jhep.2001.22499","article-title":"Hepatic uptake of organic anions affects the plasma bilirubin level in subjects with Gilbert\u2019s syndrome mutations in UGT1A1","volume":"33","author":"Persico","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.plipres.2012.11.001_b0210","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1172\/JCI59526","article-title":"Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver","volume":"122","author":"van de Steeg","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.plipres.2012.11.001_b0215","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/gtmb.2010.0132","article-title":"Association of (GT)n repeats promoter polymorphism of heme oxygenase-1 gene with serum bilirubin levels in healthy indian adults","volume":"15","author":"D\u2019Silva","year":"2011","journal-title":"Genet Test Mol Biomarkers"},{"key":"10.1016\/j.plipres.2012.11.001_b0220","doi-asserted-by":"crossref","first-page":"e764","DOI":"10.1542\/peds.2006-1385","article-title":"Marked hyperbilirubinemia associated with the heme oxygenase-1 gene promoter microsatellite polymorphism in a boy with autoimmune hemolytic anemia","volume":"119","author":"Immenschuh","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.plipres.2012.11.001_b0225","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM200102223440807","article-title":"Neonatal hyperbilirubinemia","volume":"344","author":"Dennery","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.plipres.2012.11.001_b0230","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1373\/clinchem.2008.121269","article-title":"Unbound (free) bilirubin: improving the paradigm for evaluating neonatal jaundice","volume":"55","author":"Ahlfors","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.plipres.2012.11.001_b0235","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1385\/NMM:8:4:513","article-title":"Kernicterus and the molecular mechanisms of bilirubin-induced CNS injury in newborns","volume":"8","author":"Watchko","year":"2006","journal-title":"Neuromol Med"},{"key":"10.1016\/j.plipres.2012.11.001_b0240","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1186\/1471-2164-10-543","article-title":"A transcriptome analysis identifies molecular effectors of unconjugated bilirubin in human neuroblastoma SH-SY5Y cells","volume":"10","author":"Calligaris","year":"2009","journal-title":"BMC Genomics"},{"key":"10.1016\/j.plipres.2012.11.001_b0245","first-page":"243","article-title":"Bilirubin induced apoptosis of human neuroblastoma cell line SH-SY5Y and affected the mitochondrial membrane potential","volume":"37","author":"Han","year":"2002","journal-title":"Zhonghua Er Bi Yan Hou Ke Za Zhi"},{"key":"10.1016\/j.plipres.2012.11.001_b0250","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jca.2920050107","article-title":"Multiple plasma exchanges successfully maintain a young adult patient with Crigler\u2013Najjar syndrome type I","volume":"5","author":"Ahmed","year":"1989","journal-title":"J Clin Apher"},{"key":"10.1016\/j.plipres.2012.11.001_b0255","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.fpc.0000182784.77630.48","article-title":"Study of the genetic determinants of UGT1A1 inducibility by phenobarbital in cultured human hepatocytes","volume":"16","author":"Ramirez","year":"2006","journal-title":"Pharmacogenet Genomics"},{"issue":"Suppl 2","key":"10.1016\/j.plipres.2012.11.001_b0260","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1007\/PL00014330","article-title":"Diagnosis and management of Crigler\u2013Najjar syndrome","volume":"158","author":"Jansen","year":"1999","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.plipres.2012.11.001_b0265","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1111\/j.1600-6143.2005.01084.x","article-title":"Living donor liver transplantation for pediatric patients with inheritable metabolic disorders","volume":"5","author":"Morioka","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.plipres.2012.11.001_b0270","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1126\/science.271.5252.1126","article-title":"Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene","volume":"271","author":"Paulusma","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.plipres.2012.11.001_b0275","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/CIRCULATIONAHA.112.105775","article-title":"Hyperbilirubinemia, augmentation of endothelial function, and decrease in oxidative stress in Gilbert syndrome","volume":"126","author":"Maruhashi","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.plipres.2012.11.001_b0280","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.clinbiochem.2010.12.003","article-title":"Decreased small dense LDL levels in Gilbert\u2019s syndrome","volume":"44","author":"Tapan","year":"2011","journal-title":"Clin Biochem"},{"key":"10.1016\/j.plipres.2012.11.001_b0285","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3109\/09513590.2010.493248","article-title":"Evaluation of UGT1A1 and SULT1A1 polymorphisms with lipid levels in women with different hormonal status","volume":"27","author":"Smiderle","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.plipres.2012.11.001_b0290","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1161\/CIRCULATIONAHA.106.633206","article-title":"Association between the UGT1A1\u221728 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study","volume":"114","author":"Lin","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.plipres.2012.11.001_b0295","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jsbmb.2011.08.008","article-title":"Glucuronidation of the steroid enantiomers ent-17beta-estradiol, ent-androsterone and ent-etiocholanolone by the human UDP-glucuronosyltransferases","volume":"127","author":"Sneitz","year":"2011","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.plipres.2012.11.001_b0300","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1124\/dmd.110.035030","article-title":"Correlation between bilirubin glucuronidation and estradiol-3-gluronidation in the presence of model UDP-glucuronosyltransferase 1A1 substrates\/inhibitors","volume":"39","author":"Zhou","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.plipres.2012.11.001_b0305","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/clinchem\/41.10.1504","article-title":"Serum bilirubin and risk of ischemic heart disease in middle-aged British men","volume":"41","author":"Breimer","year":"1995","journal-title":"Clin Chem"},{"key":"10.1016\/j.plipres.2012.11.001_b0310","article-title":"Relationships between serum total bilirubin levels and metabolic syndrome in Korean adults","author":"Choi","year":"2011","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.plipres.2012.11.001_b0315","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1023\/A:1013794407325","article-title":"Serum bilirubin and 10-year mortality risk in a Belgian population","volume":"12","author":"Temme","year":"2001","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.plipres.2012.11.001_b0320","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2261-12-16","article-title":"Association between bilirubin and cardiovascular disease risk factors: using Mendelian randomization to assess causal inference","volume":"12","author":"McArdle","year":"2012","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.plipres.2012.11.001_b0325","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.metabol.2007.12.003","article-title":"Association of serum bilirubin with pulsatile arterial function in asymptomatic young adults: the Bogalusa Heart Study","volume":"57","author":"Bhuiyan","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.plipres.2012.11.001_b0330","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00043798-199610000-00008","article-title":"Serum bilirubin and cardiovascular risk factors in a Chinese population","volume":"3","author":"Ko","year":"1996","journal-title":"J Cardiovasc Risk"},{"key":"10.1016\/j.plipres.2012.11.001_b0335","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1089\/jwh.2010.2453","article-title":"Inverse association between total bilirubin and metabolic syndrome in rural Korean women","volume":"20","author":"Kwon","year":"2011","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.plipres.2012.11.001_b0340","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1515\/cclm.2011.662","article-title":"Relationship between bilirubin and C-reactive protein","volume":"49","author":"Hwang","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.plipres.2012.11.001_b0345","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.cca.2010.06.003","article-title":"Inverse relationship between fasting direct bilirubin and metabolic syndrome in Korean adults","volume":"411","author":"Hwang","year":"2010","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.plipres.2012.11.001_b0350","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/jama.2011.124","article-title":"Serum bilirubin and risk of respiratory disease and death","volume":"305","author":"Horsfall","year":"2011","journal-title":"JAMA"},{"issue":"Suppl.","key":"10.1016\/j.plipres.2012.11.001_b0355","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.3346\/jkms.2009.24.S1.S22","article-title":"The mildly elevated serum bilirubin level is negatively associated with the incidence of end stage renal disease in patients with iga nephropathy","volume":"24","author":"Chin","year":"2009","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.plipres.2012.11.001_b0360","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2215\/CJN.06130710","article-title":"Serum bilirubin links UGT1A1\u221728 polymorphism and predicts long-term cardiovascular events and mortality in chronic hemodialysis patients","volume":"6","author":"Chen","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.plipres.2012.11.001_b0365","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ki.2011.341","article-title":"Antioxidant therapy in hemodialysis patients: a systematic review","volume":"81","author":"Coombes","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.plipres.2012.11.001_b0370","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.metabol.2009.04.003","article-title":"Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the sibutramine cardiovascular outcome trial","volume":"58","author":"Andersson","year":"2009","journal-title":"Metabolism"},{"key":"10.1016\/j.plipres.2012.11.001_b0375","article-title":"Genetically elevated bilirubin and risk of ischaemic heart disease: three Mendelian randomization studies and a meta-analysis","author":"Stender","year":"2012","journal-title":"J Intern Med"},{"key":"10.1016\/j.plipres.2012.11.001_b0380","doi-asserted-by":"crossref","unstructured":"Johansen CT, Hegele RA. Using Mendelian randomization to determine causative factors in cardiovascular disease. J Intern Med 2012 [Epub ahead of print].","DOI":"10.1111\/j.1365-2796.2012.02586.x"},{"key":"10.1016\/j.plipres.2012.11.001_b0385","doi-asserted-by":"crossref","first-page":"21302","DOI":"10.1016\/S0021-9258(19)30079-1","article-title":"The 3-methylcholanthrene-inducible UDP-glucuronosyltransferase deficiency in the hyperbilirubinemic rat (Gunn rat) is caused by a -1 frameshift mutation","volume":"264","author":"Iyanagi","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2012.11.001_b0390","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1172\/JCI109951","article-title":"Hepatic excretion of circulating bilirubin photoproducts in the Gunn rat","volume":"66","author":"McDonagh","year":"1980","journal-title":"J Clin Invest"},{"key":"10.1016\/j.plipres.2012.11.001_b0395","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1620\/tjem.222.265","article-title":"Hyperbilirubinemia reduces the streptozotocin-induced pancreatic damage through attenuating the oxidative stress in the Gunn rat","volume":"222","author":"Fu","year":"2010","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.plipres.2012.11.001_b0400","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1124\/jpet.106.116426","article-title":"Glucuronidation converting methyl 1-(3,4-dimethoxyphenyl)-3-(3-ethylvaleryl)-4-hydroxy-6,7,8-trimethoxy-2-naphthoat e (S-8921) to a potent apical sodium-dependent bile acid transporter inhibitor, resulting in a hypocholesterolemic action","volume":"322","author":"Sakamoto","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.plipres.2012.11.001_b0405","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.mehy.2011.03.047","article-title":"Is Gilbert syndrome a new risk factor for breast cancer?","volume":"77","author":"Astolfi","year":"2011","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.plipres.2012.11.001_b0410","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2217\/clp.11.9","article-title":"Variations in lipid levels according to menstrual cycle phase: clinical implications","volume":"6","author":"Mumford","year":"2011","journal-title":"Clin Lipidol"},{"key":"10.1016\/j.plipres.2012.11.001_b0415","doi-asserted-by":"crossref","first-page":"E80","DOI":"10.1210\/jc.2010-0109","article-title":"A longitudinal study of serum lipoproteins in relation to endogenous reproductive hormones during the menstrual cycle: findings from the biocycle study","volume":"95","author":"Mumford","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.plipres.2012.11.001_b0420","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1161\/ATVBAHA.108.181206","article-title":"Reverse cholesterol transport revisited: contribution of biliary versus intestinal cholesterol excretion","volume":"31","author":"Brufau","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2012.11.001_b0425","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/MOL.0b013e3283395e45","article-title":"Transintestinal cholesterol efflux","volume":"21","author":"van der Velde","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.plipres.2012.11.001_b0430","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/j.gastro.2004.10.006","article-title":"Increased fecal neutral sterol loss upon liver X receptor activation is independent of biliary sterol secretion in mice","volume":"128","author":"Kruit","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.plipres.2012.11.001_b0435","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1053\/j.gastro.2007.06.019","article-title":"Direct intestinal cholesterol secretion contributes significantly to total fecal neutral sterol excretion in mice","volume":"133","author":"van der Velde","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.plipres.2012.11.001_b0440","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1172\/JCI104858","article-title":"Metabolism and disposition of C14-bilirubin in congenital nonhemolytic jaundice","volume":"42","author":"Schmid","year":"1963","journal-title":"J Clin Invest"},{"key":"10.1016\/j.plipres.2012.11.001_b0445","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1096\/fj.11-195461","article-title":"Rescue of bilirubin-induced neonatal lethality in a mouse model of Crigler\u2013Najjar syndrome type I by AAV9-mediated gene transfer","volume":"26","author":"Bortolussi","year":"2012","journal-title":"FASEB J"},{"key":"10.1016\/j.plipres.2012.11.001_b0450","doi-asserted-by":"crossref","first-page":"19211","DOI":"10.1074\/jbc.M109.014860","article-title":"Activation of the liver X receptor stimulates trans-intestinal excretion of plasma cholesterol","volume":"284","author":"van der Veen","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2012.11.001_b0455","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1515\/bc.2010.065","article-title":"Contributions of the Ah receptor to bilirubin homeostasis and its antioxidative and atheroprotective functions","volume":"391","author":"Bock","year":"2010","journal-title":"Biol Chem"},{"key":"10.1016\/j.plipres.2012.11.001_b0460","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/abbi.1998.0814","article-title":"Activation of the Ah receptor signal transduction pathway by bilirubin and biliverdin","volume":"357","author":"Phelan","year":"1998","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.plipres.2012.11.001_b0465","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1515\/bc.2010.128","article-title":"An introduction to the molecular basics of aryl hydrocarbon receptor biology","volume":"391","author":"Abel","year":"2010","journal-title":"Biol Chem"},{"key":"10.1016\/j.plipres.2012.11.001_b0470","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1126\/science.7732381","article-title":"Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor","volume":"268","author":"Fernandez-Salguero","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.plipres.2012.11.001_b0475","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0006-2952(98)00134-8","article-title":"Ahr null alleles: distinctive or different?","volume":"56","author":"Lahvis","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.plipres.2012.11.001_b0480","doi-asserted-by":"crossref","first-page":"6731","DOI":"10.1073\/pnas.93.13.6731","article-title":"Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development","volume":"93","author":"Schmidt","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.plipres.2012.11.001_b0485","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/hep.25571","article-title":"Aryl hydrocarbon receptor regulates the cholesterol biosynthetic pathway in a dioxin response element-independent manner","volume":"55","author":"Tanos","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.plipres.2012.11.001_b0490","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/toxsci\/kfq024","article-title":"Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling","volume":"115","author":"DiNatale","year":"2010","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.plipres.2012.11.001_b0495","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1021\/bi901786x","article-title":"The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor","volume":"49","author":"Schroeder","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.plipres.2012.11.001_b0500","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1161\/CIRCRESAHA.108.176990","article-title":"Aryl hydrocarbon receptor is activated by glucose and regulates the thrombospondin-1 gene promoter in endothelial cells","volume":"102","author":"Dabir","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.plipres.2012.11.001_b0505","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/toxsci\/kfl100","article-title":"Comparative toxicogenomic analysis of the hepatotoxic effects of TCDD in Sprague Dawley rats and C57BL\/6 mice","volume":"94","author":"Boverhof","year":"2006","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.plipres.2012.11.001_b0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2004.12.003","article-title":"2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the mRNA expression of critical genes associated with cholesterol metabolism, bile acid biosynthesis, and bile transport in rat liver: a microarray study","volume":"207","author":"Fletcher","year":"2005","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.plipres.2012.11.001_b0515","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/toxsci\/kfr262","article-title":"Comparative metabolomic and genomic analyses of TCDD-elicited metabolic disruption in mouse and rat liver","volume":"125","author":"Forgacs","year":"2012","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.plipres.2012.11.001_b0520","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S0026-895X(25)13648-1","article-title":"Marked endogenous activation of the CYP1A1 and CYP1A2 genes in the congenitally jaundiced Gunn rat","volume":"43","author":"Kapitulnik","year":"1993","journal-title":"Mol Pharmacol"},{"issue":"2","key":"10.1016\/j.plipres.2012.11.001_b0525","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.clinre.2011.08.010","article-title":"New pathophysiological concepts underlying pathogenesis of pigment gallstones","volume":"36","author":"Vitek","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.plipres.2012.11.001_b0530","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1053\/j.gastro.2010.09.003","article-title":"Loci from a genome-wide analysis of bilirubin levels are associated with gallstone risk and composition","volume":"139","author":"Buch","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.plipres.2012.11.001_b0535","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s005350070097","article-title":"Inhibition of biliary phospholipid and cholesterol secretion by organic anions affects bile canalicular membrane composition and fluidity","volume":"35","author":"Verkade","year":"2000","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.plipres.2012.11.001_b0540","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/0016-5085(90)91180-E","article-title":"The uncoupling of biliary lipid from bile acid secretion by organic anions in the rat","volume":"99","author":"Verkade","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.plipres.2012.11.001_b0545","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/0016-5085(84)90537-7","article-title":"Inhibition of biliary phospholipid and cholesterol secretion by bilirubin in the Sprague-Dawley and Gunn rat","volume":"87","author":"Apstein","year":"1984","journal-title":"Gastroenterology"},{"key":"10.1016\/j.plipres.2012.11.001_b0550","first-page":"G462","article-title":"Mechanism of bile acid-induced biliary lipid secretion in the rat: effect of conjugated bilirubin","volume":"264","author":"Verkade","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.plipres.2012.11.001_b0555","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/hep.1840170621","article-title":"Mechanism of biliary lipid secretion in the rat: a role for bile acid-independent bile flow?","volume":"17","author":"Verkade","year":"1993","journal-title":"Hepatology"},{"issue":"Pt. 3","key":"10.1016\/j.plipres.2012.11.001_b0560","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1042\/bj3200917","article-title":"Interactions between organic anions, micelles and vesicles in model bile systems","volume":"320","author":"Verkade","year":"1996","journal-title":"Biochem J"},{"key":"10.1016\/j.plipres.2012.11.001_b0565","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1046\/j.1440-1746.1999.01917.x","article-title":"Effects of bilirubin ditaurate on biliary secretion of proteins and lipids: influence on the hepatic vesicle transport system","volume":"14","author":"Kajihara","year":"1999","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.plipres.2012.11.001_b0570","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s005350070091","article-title":"Bilirubin overload modulates bile canalicular membrane fluidity in rats: association with disproportionate reduction of biliary lipid secretion","volume":"35","author":"Kajihara","year":"2000","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.plipres.2012.11.001_b0575","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0026-895X(24)13278-6","article-title":"Hepatic expression of multidrug resistance-associated protein-like proteins maintained in eisai hyperbilirubinemic rats","volume":"53","author":"Hirohashi","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.plipres.2012.11.001_b0580","first-page":"G1493","article-title":"MRP3, a new ATP-binding cassette protein localized to the canalicular domain of the hepatocyte","volume":"276","author":"Ortiz","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.plipres.2012.11.001_b0585","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1055\/s-2007-1007171","article-title":"Roles of MRP2 and OATP1 in hepatocellular export of reduced glutathione","volume":"18","author":"Ballatori","year":"1998","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.plipres.2012.11.001_b0590","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1124\/jpet.105.098665","article-title":"Characterization of mice lacking the multidrug resistance protein MRP2 (ABCC2)","volume":"317","author":"Chu","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.plipres.2012.11.001_b0595","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2133\/dmpk.19.339","article-title":"Eisai hyperbilirubinemic rat (EHBR) as an animal model affording high drug-exposure in toxicity studies on organic anions","volume":"19","author":"Naba","year":"2004","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.plipres.2012.11.001_b0600","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0005-2736(00)00355-2","article-title":"Characterization of bile acid transport mediated by multidrug resistance associated protein 2 and bile salt export pump","volume":"1511","author":"Akita","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.plipres.2012.11.001_b0605","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.plipres.2012.11.001_b0610","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2337\/diacare.16.2.434","article-title":"Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial","volume":"16","author":"Stamler","year":"1993","journal-title":"Diabetes Care"},{"key":"10.1016\/j.plipres.2012.11.001_b0615","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(08)60104-X","article-title":"Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis","volume":"371","author":"Kearney","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.plipres.2012.11.001_b0620","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/bmj.326.7404.1423","article-title":"Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis","volume":"326","author":"Law","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.plipres.2012.11.001_b0625","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/15353702-0322805-29","article-title":"Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies","volume":"228","author":"Novotny","year":"2003","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.plipres.2012.11.001_b0630","doi-asserted-by":"crossref","first-page":"15418","DOI":"10.1074\/jbc.M111.266510","article-title":"Essential roles of Raf\/extracellular signal-regulated kinase\/mitogen-activated protein kinase pathway, YY1, and Ca2+ influx in growth arrest of human vascular smooth muscle cells by bilirubin","volume":"287","author":"Stoeckius","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2012.11.001_b0635","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1161\/CIRCULATIONAHA.104.528802","article-title":"Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation","volume":"112","author":"Ollinger","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.plipres.2012.11.001_b0640","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1159\/000091966","article-title":"The inverse association of elevated serum bilirubin levels with subclinical carotid atherosclerosis","volume":"21","author":"Vitek","year":"2006","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.plipres.2012.11.001_b0645","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fphar.2012.00119","article-title":"Heme oxygenase-1, oxidation, inflammation, and atherosclerosis","volume":"3","author":"Araujo","year":"2012","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.plipres.2012.11.001_b0650","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1478-3231.2008.01821.x","article-title":"Bilirubin concentration and cardiovascular risk profile","volume":"29","author":"Lippi","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.plipres.2012.11.001_b0655","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.clinbiochem.2009.02.005","article-title":"Soluble CD40 ligand and soluble P-selectin levels in Gilbert\u2019s syndrome: A link to protection against atherosclerosis?","volume":"42","author":"Tapan","year":"2009","journal-title":"Clin Biochem"}],"container-title":["Progress in Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163782712000598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163782712000598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T22:41:57Z","timestamp":1745361717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163782712000598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":131,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0163782712000598"],"URL":"https:\/\/doi.org\/10.1016\/j.plipres.2012.11.001","relation":{},"ISSN":["0163-7827"],"issn-type":[{"value":"0163-7827","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}